Progress in the treatment of malignant stenosis of advanced esophageal cancer with 125I radioactive stents
10.3760/cma.j.cn113030-20230417-00085
- VernacularTitle:125I放射性支架用于晚期食管癌恶性狭窄的治疗进展
- Author:
Ruiqing LI
1
;
Mawei JIANG
;
Leizhen ZHENG
Author Information
1. 上海交通大学医学院附属新华医院肿瘤科，上海 200092
- Keywords:
Esophageal neoplasms;
125I radioactive stents;
Deglutition disorders;
Malignant stenosis;
Progress
- From:
Chinese Journal of Radiation Oncology
2024;33(2):173-177
- CountryChina
- Language:Chinese
-
Abstract:
Esophageal cancer is one of the most common malignant tumors in China and dysphagia caused by malignant stenosis is the most common symptom of advanced esophageal cancer. The inability to eat orally seriously affects the quality of life of patients with advanced esophageal cancer, and poor nutritional status caused by dysphagia limits the implementation of standard treatment programs such as radiotherapy and chemotherapy, resulting in a decline in survival. The 125I radioactive stent is a novel treatment for malignant stenosis. Studies have shown that it can relieve dysphagia and prolong patients' survival compared to traditional esophageal stents. In this article, the treatment of malignant stenosis in advanced esophageal cancer and the clinical application progress of 125I radioactive stents were reviewed.
